Specify a stock or a cryptocurrency in the search bar to get a summary
60 Degrees Pharmaceuticals, Inc. Common Stock
SXTP60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is headquartered in Washington, the District of Columbia. Address: 1025 Connecticut Avenue NW, Washington, DC, United States, 20036
Analytics
WallStreet Target Price
5.5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SXTP
Dividend Analytics SXTP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SXTP
Stock Valuation SXTP
Financials SXTP
Results | 2019 | Dynamics |